Efficacy, Safety, and Tolerability of Levomilnacipran ER in Pediatric (7-17 Years) With Major Depressive Disorder
about
Efficacy, Safety, and Tolerability of Levomilnacipran ER in Pediatric (7-17 Years) With Major Depressive Disorder
description
clinical trial
@en
klinisch onderzoek
@nl
name
Efficacy, Safety, and Tolerabi ...... With Major Depressive Disorder
@en
type
label
Efficacy, Safety, and Tolerabi ...... With Major Depressive Disorder
@en
prefLabel
Efficacy, Safety, and Tolerabi ...... With Major Depressive Disorder
@en
P6153
P1476
A Double-blind, Placebo- and A ...... With Major Depressive Disorder
@en
P3098
NCT03569475
P580
2018-07-06T00:00:00Z
P582
2021-10-21T00:00:00Z